Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06857305
What this trial is testing

Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial

Who this might be right for
Breast Cancer Metastatic
Ma Fei，MD 192
Not applicableActive Not RecruitingNCT04512937
What this trial is testing

Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer

Who this might be right for
Rectal Cancer
Oslo University Hospital 20
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05476796
What this trial is testing

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagus AdenocarcinomaGastroesophageal Junction Adenocarcinoma
UNICANCER 118
Testing effectiveness (Phase 2)WithdrawnNCT00503932
What this trial is testing

Proton Therapy With Capecitabine for Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06307548
What this trial is testing

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Who this might be right for
Locally Advanced Colorectal CarcinomaRecurrent Colorectal CarcinomaStage III Colorectal Cancer
Roswell Park Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT01243385
What this trial is testing

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 44
Early research (Phase 1)Looking for participantsNCT06390774
What this trial is testing

Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors

Who this might be right for
Locally Advanced, Recurrent or Metastatic Malignancies
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 180
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT05019703
What this trial is testing

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Who this might be right for
Locally Advanced OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma+2 more
M.D. Anderson Cancer Center 40
Not applicableWithdrawnNCT02017925
What this trial is testing

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
CachexiaFatiguePulmonary Complications+5 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00408252
What this trial is testing

Efficacy of SU 011248 in Head And Neck Carcinoma

Who this might be right for
Recurrent DiseaseSquamous Cell Head and Neck CarcinomaPalliative Treatment
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 54
Large-scale testing (Phase 3)Study completedNCT01767155
What this trial is testing

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

Who this might be right for
Endometrial Cancer
AEterna Zentaris 511
Not applicableStudy completedNCT07351708
What this trial is testing

Development and Validation of a Post-operative Risk Of Local Recurrence Model Integrating Serology and Evalution (PROMISE) in Local Advanced Rectal Cancer Receiving Neoadjuvant Therapy: a Multicenter Study

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Cai Zerong 2,315
Large-scale testing (Phase 3)Ended earlyNCT02054338
What this trial is testing

Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Pierre Fabre Medicament 1,004
Early research (Phase 1)Looking for participantsNCT06211335
What this trial is testing

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaRefractory Head and Neck Squamous Cell Carcinoma
University of California, Davis 24
Testing effectiveness (Phase 2)Looking for participantsNCT05628038
What this trial is testing

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

Who this might be right for
Recurrent Rectal Cancer
Fudan University 93
Early research (Phase 1)Study completedNCT01071304
What this trial is testing

Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)

Who this might be right for
Relapsed or Refractory Advanced Cancer
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT01447706
What this trial is testing

MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Merrimack Pharmaceuticals 223
Testing effectiveness (Phase 2)Ended earlyNCT04191135
What this trial is testing

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 462
Next Page